Introduction: Hearing loss represents one of the most frequent human disabilities. Hair cells, the primary sound receptors located in the inner ear are extremely sensitive, but also very fragile. Thedestruction of these cells in humans or in any other mammal is not followed by replacement, and therefore a permanent hearing loss results. Material and Methods: Neonatal mousse CD1 (P0-6) were sacrificed according to the legal standards and ethics. After manual dissection of the cochleae, the entire spiral ganglion was dissected from the modiolus. The explants were treated with gentamicin, followed by incubation for 48 hours at 37°C. Normal and damaged outer hair cells (OHC) or inner hair cells (IHC) were then counted toallow for statistical co...
peer reviewedThe ototoxic damage that drugs such as neomycin, kanamycin, colistin, cisplatin, transp...
Aims: Ototoxicity is one of the main side effects of the chemotherapeutic agent Cisplatin (CDDP). CD...
<p><b>A–B</b>': P2 Lfng/GFP transgenic control (A, A') and gentamicin treated (B, B') cochlear cultu...
A wide variety of ototoxic drugs are capable of damaging the sensory hair cells in the mammalian coc...
The early identification of hearing impairment allows for an intervention still in the ""critical"" ...
AbstractTo gain insights into the ototoxic effects of aminoglycoside antibiotics (AmAn) and delayed ...
SummaryThe early identification of hearing impairment allows for an intervention still in the “criti...
Summary: Ototoxicity is still a challenge to medicine. The discovery of self-protecting endogenous m...
<p>A) Low magnification image of a postnatal 3-day-old (P3) mouse cochlea immunolabeled for myosin7a...
<p>(A) Quantification of inner hair cells (IHCs) and outer hair cells (OHCs) in organ of Corti (OC) ...
Hair cells in the cochlea can be damaged by various causes. Damaged hair cells can lead to additiona...
Gentamicin sulphate is used clinically to produce vestibular organ damage in patients with intractab...
Conclusion. The gentamicin-induced pathological alteration in the cochlear nucleus is not exclusivel...
Objective/Hypothesis: Although most studies have identified damage in the cochlea and semicircular c...
<p><b>A–C:</b> Hair cell phenotype in control (A, A'), gentamicin +DMSO (B, B') and gentamicin +DAPT...
peer reviewedThe ototoxic damage that drugs such as neomycin, kanamycin, colistin, cisplatin, transp...
Aims: Ototoxicity is one of the main side effects of the chemotherapeutic agent Cisplatin (CDDP). CD...
<p><b>A–B</b>': P2 Lfng/GFP transgenic control (A, A') and gentamicin treated (B, B') cochlear cultu...
A wide variety of ototoxic drugs are capable of damaging the sensory hair cells in the mammalian coc...
The early identification of hearing impairment allows for an intervention still in the ""critical"" ...
AbstractTo gain insights into the ototoxic effects of aminoglycoside antibiotics (AmAn) and delayed ...
SummaryThe early identification of hearing impairment allows for an intervention still in the “criti...
Summary: Ototoxicity is still a challenge to medicine. The discovery of self-protecting endogenous m...
<p>A) Low magnification image of a postnatal 3-day-old (P3) mouse cochlea immunolabeled for myosin7a...
<p>(A) Quantification of inner hair cells (IHCs) and outer hair cells (OHCs) in organ of Corti (OC) ...
Hair cells in the cochlea can be damaged by various causes. Damaged hair cells can lead to additiona...
Gentamicin sulphate is used clinically to produce vestibular organ damage in patients with intractab...
Conclusion. The gentamicin-induced pathological alteration in the cochlear nucleus is not exclusivel...
Objective/Hypothesis: Although most studies have identified damage in the cochlea and semicircular c...
<p><b>A–C:</b> Hair cell phenotype in control (A, A'), gentamicin +DMSO (B, B') and gentamicin +DAPT...
peer reviewedThe ototoxic damage that drugs such as neomycin, kanamycin, colistin, cisplatin, transp...
Aims: Ototoxicity is one of the main side effects of the chemotherapeutic agent Cisplatin (CDDP). CD...
<p><b>A–B</b>': P2 Lfng/GFP transgenic control (A, A') and gentamicin treated (B, B') cochlear cultu...